X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (27810) 27810
Newsletter (5205) 5205
Newspaper Article (4040) 4040
Book Review (3784) 3784
Publication (1685) 1685
Trade Publication Article (218) 218
Magazine Article (156) 156
Conference Proceeding (127) 127
Book Chapter (121) 121
Dissertation (110) 110
Web Resource (43) 43
Book / eBook (16) 16
Reference (7) 7
Data Set (4) 4
Transcript (4) 4
Paper (3) 3
Government Document (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bladder cancer (27823) 27823
index medicus (18820) 18820
humans (16880) 16880
cancer (13325) 13325
oncology (10725) 10725
male (9346) 9346
female (8852) 8852
research (8753) 8753
middle aged (7203) 7203
bladder-cancer (7131) 7131
aged (7130) 7130
urinary bladder neoplasms - pathology (6058) 6058
urology & nephrology (5745) 5745
tumors (5594) 5594
care and treatment (5132) 5132
oncology, experimental (4742) 4742
adult (4361) 4361
prognosis (4305) 4305
chemotherapy (4076) 4076
metastasis (4038) 4038
carcinoma (3804) 3804
aged, 80 and over (3676) 3676
analysis (3615) 3615
genetic aspects (3563) 3563
expression (3388) 3388
urology (3321) 3321
apoptosis (3273) 3273
health aspects (3126) 3126
risk factors (2918) 2918
animals (2913) 2913
development and progression (2808) 2808
urinary bladder neoplasms - genetics (2778) 2778
diagnosis (2744) 2744
urothelial carcinoma (2599) 2599
gene expression (2517) 2517
transitional-cell carcinoma (2473) 2473
cell line, tumor (2418) 2418
bladder (2392) 2392
cancer therapies (2331) 2331
urinary bladder neoplasms - surgery (2325) 2325
urinary bladder neoplasms - drug therapy (2319) 2319
reports (2296) 2296
proteins (2253) 2253
carcinoma, transitional cell - pathology (2185) 2185
neoplasm staging (2184) 2184
immunotherapy (2142) 2142
survival (2004) 2004
cystectomy (1927) 1927
urinary bladder neoplasms - metabolism (1924) 1924
radical cystectomy (1905) 1905
immunohistochemistry (1879) 1879
abridged index medicus (1877) 1877
treatment outcome (1844) 1844
patients (1754) 1754
pathology (1728) 1728
medical research (1718) 1718
studies (1702) 1702
progression (1701) 1701
retrospective studies (1695) 1695
neoplasm invasiveness (1688) 1688
risk (1679) 1679
recurrence (1668) 1668
mice (1632) 1632
surgery (1625) 1625
breast-cancer (1620) 1620
cell biology (1598) 1598
urinary bladder neoplasms - diagnosis (1556) 1556
urinary bladder neoplasms - mortality (1548) 1548
urinary bladder neoplasms - therapy (1528) 1528
medical prognosis (1477) 1477
urinary-bladder (1468) 1468
prostate cancer (1428) 1428
urinary bladder (1401) 1401
urine (1397) 1397
genes (1392) 1392
biomarkers (1390) 1390
medicine & public health (1369) 1369
gene expression regulation, neoplastic (1354) 1354
medicine (1336) 1336
clinical trials (1333) 1333
health risk assessment (1321) 1321
biochemistry & molecular biology (1315) 1315
universities and colleges (1302) 1302
therapy (1295) 1295
transitional-cell-carcinoma (1278) 1278
cell cycle (1268) 1268
prostate-cancer (1254) 1254
cells (1237) 1237
cisplatin (1197) 1197
drug therapy (1193) 1193
follow-up studies (1186) 1186
lung-cancer (1154) 1154
cell proliferation (1141) 1141
case-control studies (1134) 1134
medicine, research & experimental (1132) 1132
disease progression (1117) 1117
carcinoma, transitional cell - surgery (1105) 1105
cell growth (1103) 1103
lung cancer (1096) 1096
mutation (1094) 1094
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (36721) 36721
German (367) 367
French (237) 237
Japanese (128) 128
Spanish (80) 80
Chinese (75) 75
Russian (42) 42
Korean (19) 19
Turkish (16) 16
Polish (7) 7
Hungarian (5) 5
Portuguese (4) 4
Swedish (3) 3
Slovak (2) 2
Croatian (1) 1
Dutch (1) 1
Italian (1) 1
Lithuanian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, pp. e40311 - e40311
Dendritic cells (DC) can achieve cross-presentation of naturally-occurring tumor-associated antigens after phagocytosis and processing of dying tumor cells.... 
METASTATIC MELANOMA | HUMAN TUMOR-ANTIGEN | HLA-A2 MELANOMAS | B16 MELANOMA | MULTIDISCIPLINARY SCIENCES | IN-VIVO | APOPTOTIC CELLS | VACCINATION | PHASE-II | CROSS-PRESENTATION | LYMPHOCYTES | MART-1 Antigen - immunology | Melanoma - metabolism | Gamma Rays | HLA-A2 Antigen - immunology | Antigen Presentation - radiation effects | Dendritic Cells - immunology | Humans | Phagocytosis - immunology | Gene Expression Regulation, Neoplastic - immunology | Interferon-gamma - metabolism | Antigen Presentation - immunology | Phagocytosis - radiation effects | Microscopy, Confocal | Macrophages - metabolism | Melanoma - immunology | Interferon-gamma - immunology | CD8-Positive T-Lymphocytes - metabolism | Cell Line, Tumor | Gene Expression Regulation, Neoplastic - radiation effects | MART-1 Antigen - biosynthesis | HLA-A2 Antigen - metabolism | CD8-Positive T-Lymphocytes - immunology | Dendritic Cells - metabolism | Macrophages - immunology | Biotechnology | Peptides | CD8 antigen | Antigen processing | Irradiated | Clinical trials | Confocal microscopy | Mesothelioma | Lymphocytes T | Vaccines | Macrophages | Cancer therapies | Phagocytes | Killer cells | Lymphocytes | Immunotherapy | Stains | Antigen presentation | Antigens | Medical research | Dendritic cells | Granulocyte-macrophage colony-stimulating factor | Tumor cells | Melanoma | BCG | Cultures | Patients | Bladder cancer | Microscopy | Antigen-presenting cells | Antigen (tumor-associated) | Cell lines | Antitumor activity | Interferon | Histocompatibility antigen HLA | Phagocytosis | Tumors | Cancer | Apoptosis | Index Medicus | Antibodies | Melanocytes | MART-1 antigen | gamma Radiation | gamma -Interferon
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, pp. e37601 - e37601
Background: MicroRNAs (miRs) are small non-coding RNAs that play an important role in cancer development where they can act as oncogenes or as... 
SMALL RNAS | SEVERITY STAGING SYSTEM | 5-YEAR SURVIVAL RATES | SIGNALING PATHWAY | ENDOTHELIAL-CELLS | OROPHARYNGEAL CANCER | BIOLOGY | GENE-EXPRESSION | DOWN-REGULATION | SUPPRESSIVE MIR-34A | C-MET EXPRESSION | Cell Proliferation | Inhibitor of Apoptosis Proteins - genetics | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Gene Expression Regulation, Neoplastic | MicroRNAs - metabolism | Head and Neck Neoplasms - metabolism | Neovascularization, Pathologic - pathology | Cell Transformation, Neoplastic - genetics | Inhibitor of Apoptosis Proteins - metabolism | Endothelial Cells - metabolism | Down-Regulation | Cell Transformation, Neoplastic - metabolism | Head and Neck Neoplasms - pathology | Animals | Cell Line, Tumor | Head and Neck Neoplasms - genetics | Neovascularization, Pathologic - genetics | Mice | MicroRNAs - genetics | Neovascularization, Pathologic - metabolism | Cell Transformation, Neoplastic - pathology | Endothelial Cells - pathology | Squamous cell carcinoma | MicroRNA | Growth | Development and progression | B cells | Vascular endothelial growth factor | Health aspects | Endothelium | Cell proliferation | Biotechnology | Severe combined immunodeficiency | Leukocyte migration | Otolaryngology | Metastasis | Neuroblastoma | Cancer therapies | DNA repair | Proteins | Angiogenesis | Human papillomavirus | Cell growth | Surgery | Xenografts | Tumorigenesis | Larynx | Inhibition | Neck | Head | Cell survival | Colonies | Tumor cells | MiRNA | Survivin | Tumor cell lines | Gene expression | Ribonucleic acid--RNA | Bladder cancer | Suppressors | Endothelial cells | MicroRNAs | Medical prognosis | Cell lines | Isoforms | Head and neck cancer | Head & neck cancer | Cell migration | Tumors | Cancer | Apoptosis | Index Medicus | RNA | Ribonucleic acid
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 08/2017, Volume 127, Issue 8, pp. 2916 - 2929
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, pp. e0168406 - e0168406
Acquired resistance to tamoxifen remains a major obstacle in breast cancer (BC) treatment, since the underlying mechanism has not been fully elucidated. The... 
DRUG-RESISTANCE | MULTIDISCIPLINARY SCIENCES | ESTROGEN-RECEPTOR-ALPHA | GROWTH | Cell Proliferation - genetics | Humans | Cell Proliferation - physiology | Wnt Signaling Pathway - physiology | Apoptosis - genetics | RNA, Long Noncoding - genetics | RNA, Long Noncoding - physiology | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | beta Catenin - metabolism | beta Catenin - genetics | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | MCF-7 Cells | Wnt Signaling Pathway - genetics | Tamoxifen - pharmacology | Cell Line, Tumor | Female | Mice | Apoptosis - physiology | Drug Resistance, Neoplasm - physiology | RNA, Long Noncoding - metabolism | Biotechnology | Flow cytometry | Wnt protein | Estrogen | Oncology | Activation | Metastasis | Drug resistance | Assaying | Experiments | Cancer therapies | Ovarian cancer | β-catenin | Signal transduction | Cell growth | Animal tissues | Quality | Xenografts | Cell cycle | Tumorigenesis | Inhibition | Urothelial carcinoma | Cell survival | Invasiveness | Breast cancer | Tumorigenicity | Tamoxifen | Ribonucleic acid--RNA | Patients | Bladder cancer | Cytometry | Signaling | Sensitivity | Cell lines | Stem cells | Breast | Sensitivity enhancement | Immunofluorescence | Non-coding RNA | Viability | Apoptosis | Cancer | Index Medicus | RNA | Ribonucleic acid
Journal Article
Journal Article
Cancer Investigation, ISSN 0735-7907, 2008, Volume 26, Issue 7, pp. 725 - 733
Bladder cancer stem (initiating) cell has not been isolated now, and no one verified its persistence experimentally. The aim of this study was to conclude the... 
EMA | Side population cells | CD44v6 | Bladder transitional cell carcinomas | Cancer stem cells | Bladder cancer stem (initial) cells | Surface markers | BMI-1 ONCOPROTEIN | URINARY-BLADDER | PROSPECTIVE IDENTIFICATION | bladder transitional cell carcinomas | CD44 SPLICE VARIANTS | side population cells | PROGNOSTIC VALUE | surface markers | EPITHELIAL MEMBRANE ANTIGEN | BREAST-CANCER | HEMATOPOIETIC PROGENITOR CELLS | ONCOLOGY | bladder cancer stem (initial) cells | COLORECTAL-CANCER | PROSTATE-CANCER | cancer stem cells | Immunohistochemistry | Cell Proliferation | Urothelium - metabolism | Oligonucleotide Array Sequence Analysis | Humans | Gene Expression Regulation, Neoplastic | Neoplastic Stem Cells - immunology | Urothelium - pathology | Immunomagnetic Separation - methods | DNA-Binding Proteins - metabolism | Urinary Bladder Neoplasms - genetics | Neoplastic Stem Cells - metabolism | Cell Shape | Hyaluronan Receptors - metabolism | Urinary Bladder Neoplasms - pathology | Biomarkers, Tumor - metabolism | Neoplastic Stem Cells - pathology | Cell Differentiation | Tumor Cells, Cultured | Nuclear Proteins - genetics | Urinary Bladder Neoplasms - metabolism | Repressor Proteins - metabolism | Proto-Oncogene Proteins - metabolism | Tumor Stem Cell Assay | Mucin-1 - metabolism | Repressor Proteins - genetics | Gene Expression Profiling - methods | Nuclear Proteins - metabolism | Proto-Oncogene Proteins - genetics | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Enhancer of Zeste Homolog 2 Protein | Transcription Factors - metabolism | Polycomb Repressive Complex 2 | Polycomb Repressive Complex 1 | Urothelium - immunology | Urinary Bladder Neoplasms - immunology | Microscopy, Fluorescence | Index Medicus
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 01/2019, Volume 68, Issue 1, pp. 45 - 56
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7693, pp. 544 - 548
Therapeutic antibodies that block the programmed death-1 (PD-1)-programmed death-ligand 1 (PD-L1) pathway can induce robust and durable responses in patients... 
METASTATIC MELANOMA | CTLA-4 BLOCKADE | BLADDER-CANCER | THERAPY | LANDSCAPE | SUBTYPES | UROTHELIAL CARCINOMA | MULTIDISCIPLINARY SCIENCES | GENES | ADAPTIVE IMMUNE RESISTANCE | MPDL3280A | CD8-Positive T-Lymphocytes - cytology | Humans | Antibodies, Monoclonal - therapeutic use | Urothelium - pathology | Urologic Neoplasms - pathology | Neoplasm Metastasis | Urologic Neoplasms - drug therapy | Urologic Neoplasms - genetics | Immunotherapy | Antibodies - immunology | Antigens, Neoplasm - metabolism | Transforming Growth Factor beta - antagonists & inhibitors | Antigens, Neoplasm - analysis | Disease Models, Animal | Fibroblasts - metabolism | Antibodies - therapeutic use | Antigens, Neoplasm - immunology | Antibodies, Monoclonal - pharmacology | Treatment Outcome | B7-H1 Antigen - immunology | Urologic Neoplasms - immunology | Antibodies - pharmacology | Tumor Microenvironment - immunology | Collagen - metabolism | Phenotype | Animals | B7-H1 Antigen - antagonists & inhibitors | Signal Transduction - drug effects | Cell Cycle Checkpoints - drug effects | CD8-Positive T-Lymphocytes - drug effects | Urothelium - immunology | Mice | Mutation | CD8-Positive T-Lymphocytes - immunology | Urothelium - drug effects | Transforming Growth Factor beta - metabolism | Cohort Studies | Drug Resistance, Neoplasm - drug effects | PD-1 protein | CD8 antigen | Transforming growth factor-a | Antibodies | Parenchyma | Lymphocytes T | Metastasis | Immunity | Metastases | Genotype & phenotype | Signal transduction | Lymphocytes | Cell cycle | Fibroblasts | Growth factors | Urothelial cancer | Phenotypes | Cytokines | Melanoma | Blocking | Gene expression | Patients | Generalized linear models | Signaling | Stromal cells | Medical prognosis | Collagen | PD-L1 protein | Ligands | Determinants | Infiltration | Cancer | Tumors | Apoptosis | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, pp. e0173725 - e0173725
Renal cell carcinoma (RCC) is known as one of the most lethal malignancies in the urological system because of its high incidence of metastasis. Tetrandrine... 
APOPTOSIS | ACTIVATION | METASTASIS | THERAPY | PATHWAY | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER CELLS | PROLIFERATION | KAPPA-B | MMP-9 | EXPRESSION | Carcinoma, Renal Cell - pathology | Humans | NF-kappa B - metabolism | Kidney Neoplasms - metabolism | Phosphatidylinositol 3-Kinases - metabolism | 3-Phosphoinositide-Dependent Protein Kinases - metabolism | Carcinoma, Renal Cell - metabolism | Cell Movement - drug effects | Matrix Metalloproteinase 9 - metabolism | Signal Transduction - drug effects | Cell Line, Tumor | Kidney Neoplasms - pathology | Cell Proliferation - drug effects | Phosphorylation - drug effects | Antineoplastic Agents, Phytogenic - pharmacology | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy | Proto-Oncogene Proteins c-akt - metabolism | Benzylisoquinolines - pharmacology | Matrix metalloproteinases | Oncology | AKT protein | Retailing | Metastasis | Cancer therapies | Urology | Metastases | Anticancer properties | Angiogenesis | Signal transduction | Restoration | Cell cycle | Inhibition | NF-κB protein | Tetrandrine | Urological system | Breast cancer | Bladder cancer | Gelatinase B | 1-Phosphatidylinositol 3-kinase | Herbal medicine | Signaling | Chemotherapy | Hospitals | Inhibitors | Microscopy | Prostate cancer | Cell migration | Clear cell-type renal cell carcinoma | Cancer | Apoptosis | Index Medicus
Journal Article